Advertisement

Topics

A549 Cells: Lung Carcinoma Cell Line for Adenovirus

20:00 EDT 1 Nov 2016 | NIH

Scientists at the National Cancer Institute developed a cell line designated A549 that was derived from explanted cultures of human lung cancer tissue. The A549 cell line has been tested under the guidance of the United States Food and Drug Administration (FDA) so, under current Good Manufacturing Practices (GMP), these cells may be suitable for use in manufacturing constructs for use in clinical trials. The A549 cell line has also been found to be suitable for adenovirus production, most notably replicating adenovirus constructs that do not require complementation by the viral oncogene, early region 1A (E1A), which is responsible for viral gene transcription. This cell line is further utilized as a negative control in assays to measure the replication of adenoviruses that lack E1A and as a target cell line to detect replication competent adenoviruses (RCA). A549 cells have been well characterized through their use in a wide variety of molecular studies, such as anti-tumor drug permeability and efficacy analysis, infection assays, respiratory immunotoxicity tests, cell senescence studies, and cytokine expression profiling. These cells can also be utilized to study a variety of molecular characteristics for human tumors in culture.

IC: 
NCI
NIH Ref. No.: 
E-129-2009
Advantages: 
  • A549 cells are a well-characterized standard among the human lung carcinoma/alveolar cell lines used in molecular biology.
  • The A549 cells stored at the NIH were tested under the guidance of the FDA’s cGMP regulations and may be suitable for producing adenoviruses that can be used in clinical trials and analyzing adenoviral-based therapies and vaccine strategies.
Applications: 
  • Cell bank tested under cGMP-compliance regulations and used to produce adenoviruses for use in clinical trials
  • Research tool to analyze the efficacy of potential anti-cancer agents to devise better cancer treatments for malignancies, such as non-small cell lung cancer (NSCLC)
  • Research tool to study the infectivity of viruses that cause asthma in order to develop better asthma treatments
  • Standard research tool to analyze a variety of molecular biology procedures, for example, cell senescence, cytokine induction, protein expression, apoptosis, and receptor-ligand interactions
Development Status: 

Basic (Target Identification)

Updated On: 
May 30, 2018
Date Published: 
Wednesday, November 2, 2016
Provider Classifications: 
Publications: 
Licensing Contacts: 
Lead Inventor: 
Inventor IC: 
NCI
NCI
LPM FIrst Name: 
John
LPM Last Name: 
Hewes
Inv Is lead: 
LPM Phone: 
240-276-5515
LPM Suffix: 
Ph.D.
LPM Organization: 
NCI - National Cancer Institute
DTDT Classification: 
Research Materials
DTDT Description: 
Research Materials
Publication Link: 
https://www.ncbi.nlm.nih.gov/pubmed/4357758
Publication Title: 

D.J. Giard et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417-1423.

Collaboration Sought: 
Yes
Institute or Center: 
Collaboration Opportunity: 

Licensing only

E Number Only: 
E-129-2009
Inventor First Name: 
Wade
Stuart
Donald
Inventor Last Name: 
Parks
Aaronson
Giard

Original Article: A549 Cells: Lung Carcinoma Cell Line for Adenovirus

NEXT ARTICLE

More From BioPortfolio on "A549 Cells: Lung Carcinoma Cell Line for Adenovirus"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...